Skip to main content
SpringerLink
Log in

Recommendations for the Assessment of Adjuvants (Immunopotentiators)

  • Chapter
Immunological Adjuvants and Vaccines

Part of the book series: NATO ASI Series ((NSSA,volume 179))

Abstract

During the last decade there has been a significant expansion in the field of adjuvant research in many countries due, in part, to the success of the techniques of genetic manipulation, nucleotide sequencing and peptide synthesis. The potential exists to formulate totally synthetic vaccines (Jolivet et al, 1987) but it is also realized that the successful use of the new technologies will require a continued research effort to find adjuvant substances which do not have adverse biological properties (Vane and Cuatrecasas, 1984; Paquet et al, 1986; Stewart-Tull, 1988).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allison, A.C., Byars, N.E. and Waters, R.V., 1986, “Advances in Carriers and Adjuvants for Veterinary Biologics”, R.M. Nervig. P.M. Gough, M.L. Kaeberle and C.A. Whetstone, eds., Iowa State University Press, Ames, Iowa.

    Google Scholar 

  • Byars, N.E. and Allison, A.C., 1987, Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity, Vaccine, 5: 223.

    Article  PubMed  CAS  Google Scholar 

  • Davenport, F.M., 1968, Seventeen years’ experience with mineral oil adjuvant influenza virus vaccines, Ann. Allergy, 26: 288.

    PubMed  CAS  Google Scholar 

  • Edelman, R., 1980, Vaccine adjuvants, Rev.Infect.Dis., 2: 370.

    Article  PubMed  CAS  Google Scholar 

  • Friedewald, W. F., 1944a, Adjuvants in immunization with influenza virus vaccines, J.Exp.Med., 80: 477.

    Article  PubMed  CAS  Google Scholar 

  • Friedewald, W.F., 1944b, Enhancement of the immunizing capacity of influenza virus vaccines with adjuvants, Science, 99: 453.

    Article  PubMed  CAS  Google Scholar 

  • Gisler, R.H., Dietrich, F.M., Baschang, G., Brownbill, A., Schumann, G., Staber, F.G., Tarcsay, L., Wachsmuth, E.D. and Dukor, P., 1979, “Drugs and Immune Responsiveness”, J.L. Turk and D. Parker, eds., Macmillan Press, London.

    Google Scholar 

  • Gray, J.E., Weaver, R.N., Moran, J. and Feenstra, E.S., 1974, The parenteral toxicity of clindamycin 2-phosphate in laboratory animals, Toxicol. Appl. Pharmacol., 27: 308.

    Article  PubMed  CAS  Google Scholar 

  • Henle, W. and Henle, G., 1945, Effect of adjuvants on vaccination of human beings against influenza, Proc.Soc.Exptl.Biol.Med., 59: 179.

    Google Scholar 

  • Hughes, B.P., 1962, A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera, Clin.Chim.Acta, 7: 579.

    Article  Google Scholar 

  • Jolivet, M.E., Audibert, F.M., Gras-Masse, H., Tartar, A.L., Schlesinger, D.H., Wirtz, R. and Chedid, L.A., 1987, Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier, Infect. Immun., 55: 1498.

    PubMed  CAS  Google Scholar 

  • MacLennan, R., Schofield, F.D., Pittman, M., Hardegree, M.C. and Barile, M.F., 1965, Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids, Bull.WHO, 32: 683.

    PubMed  CAS  Google Scholar 

  • Mancini, G., Carbonara, A.O. and Heremans, J.F., 1965, Immunochemical quantitation of antigens by single radial immunodiffusion, Immunochemistry, 2: 235.

    Article  PubMed  CAS  Google Scholar 

  • Miller, H.R.P., Woodbury, R.G., Huntley, J.F. and Newlands, G., 1983, Systemic release of mucosal mast-cell protease in primed rats challenged with Nippostrongylus brasiliensis, Immunology, 49: 471.

    CAS  Google Scholar 

  • Murray, R., Cohen, P. and Hardegree, M.C, 1972, Mineral oil adjuvants: biological and chemical studies, Ann. Allergy, 30: 146

    PubMed  CAS  Google Scholar 

  • Ogonuki, H., Hashizume, S. and Abe, H., 1967, Histophathological tests of tissues in the sites of local reactions caused by the injection of oil-adjuvant cholera vaccine, Symp. Ser. Immunobiol. Stand., 6: 125.

    Google Scholar 

  • Paquet, A., Raines, K.M. and Brownback, P.C., 1986, Immunopotentiating activities of cell walls, peptidoglycans and teichoic acids from two strains of Listeria monocytogenes, Infect. Immun., 54: 170.

    CAS  Google Scholar 

  • Pearson, C.M. and Wood, F.D., 1959, Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors, Arthritis and Rheumatism, 2: 440.

    Article  Google Scholar 

  • Rasanen, L., Mustikkamaki, U.P. and Arvilommi, H., 1982, Polyclonal response of human lymphocytes to bacterial cell walls, peptidoglycans and teichoic acids, Immunology, 46: 481.

    PubMed  CAS  Google Scholar 

  • Rethy, L., 1965, The production and use of a stable aluminium hydroxide adsorbent, Prog.Immunobiol.Stand., 2: 80.

    Google Scholar 

  • Schmidt, G., 1967, The adjuvant effect of aluminium hydroxide in influenza vaccine. International Symposium on Adjuvants of Immunity, Utrecht, 1966, Sym.Ser.Immunobiol.Stand., 6: 275.

    Google Scholar 

  • Stewart-Tull, D.E.S., 1980, The immunological activities of bacterial peptidocylcans, Ann. Rev. Microbiol., 34: 311.

    Article  CAS  Google Scholar 

  • Stewart-Tull, D.E.S., 1983, Immunologically important constituents of mycobacteria: adjuvants, in: “Biology of Mycobacteria”, Vol. 2, C. Ratledge and J. Stanford, eds., Academic Press, London.

    Google Scholar 

  • Stewart-Tull, D.E.S., 1985a, Immunopotentiating conjugates, Vaccine, 3: 40.

    Article  PubMed  CAS  Google Scholar 

  • Stewart-Tull, D.E.S., 1985b, Immunopotentiating activity of peptidoglycan and surface polymers, in: “Immunology of the Bacterial Cell Envelope”, D.E.S. Stewart-Tull and M. Davies, eds., John Wiley & Sons, Chichester.

    Google Scholar 

  • Stewart-Tull, D.E.S., 1988, Immunostimulation with peptidoglycan or its synthetic derivatives, Prog. Drug Res., 32, in press.

    Google Scholar 

  • Stewart-Tull, D.E.S. and Parant, M., 1986, Immunopotentiators in vaccines: a dream to a reality, Arm. Immunol. Hung., 26: 197.

    CAS  Google Scholar 

  • Vane, J. and Cuatrecasas, P., 1984, Genetic engineering and pharmaceuticals, Nature, 312: 303.

    Article  PubMed  CAS  Google Scholar 

  • Waksman, B.H., Pearson, C.M. and Sharp. J.T., 1960, Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvants. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen, J. Immunol. 85: 403.

    PubMed  CAS  Google Scholar 

  • Wardlaw, A.C., 1985, “Practical Statistics for Experimental Biologists”, John Wiley & Sons, Chichester.

    Google Scholar 

  • Waters, R.V., Terrell, T.G. and Jones, G.H., 1986, Uveitis induction in the rabbit by muramyl dipeptides, Infect.Immun., 51: 816.

    PubMed  CAS  Google Scholar 

  • Weeke, B., Weeke, E. and Lowenstein, H., 1975, The adsorption of serum proteins to aluminium hydroxide gel examined by means of quantitative Immunoelectrophoresis, Scand. J. Immunol., 4: 149.

    Article  Google Scholar 

  • World Health Organization, 1976, Immunological adjuvants, Techn.Rep.Ser., 595: 3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Microbiology Department, Alexander Stone Building Garscube Estate, Bearsden, Glasgow, G61 1QH, UK

    D. E. S. Stewart-Tull

Authors
  1. D. E. S. Stewart-Tull
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Royal Free Hospital School of Medicine, London, UK

    Gregory Gregoriadis

  2. Syntex Research, Palo Alto, California, USA

    Anthony C. Allison

  3. Smith Kline French Laboratories, Philadelphia, Pennsylvania, USA

    George Poste

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Stewart-Tull, D.E.S. (1989). Recommendations for the Assessment of Adjuvants (Immunopotentiators). In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Immunological Adjuvants and Vaccines. NATO ASI Series, vol 179. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0283-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0283-5_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0285-9

  • Online ISBN: 978-1-4757-0283-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation